Welcome to the New Restek.com! Take a tour of the new site and feel free to send us your feedback.
Your web browser will no longer be supported by Restek.com as of 30 June 2021.
To avoid any interruption in access or functionality, install a current-generation web browser now. Learn more.

Ethyl Glucuronide (EtG) and Ethyl Sulfate (EtS) in Oral Fluid on Raptor EtG/EtS

PeakstR (min)Conc.
Precursor IonProduct IonProduct Ion
3.Ethyl sulfate-d51.75100129.897.7-
4.Ethyl sulfate1.78500124.896.879.7
ColumnRaptor EtG/EtS (cat.# 9325A12)
Dimensions:100 mm x 2.1 mm ID
Particle Size:2.7 µm
Pore Size:90 Å
Guard Column:UltraShield UHPLC precolumn filter (cat.# 25809)
Temp.:30 °C
SampleEthyl-β-D-glucuronide (EtG) (cat.# 34101)
Ethyl-β-D-glucuronide-d5 (EtG-d5) (cat.# 34102)
Ethyl sulfate sodium salt (EtS) (cat.# 34103)
Ethyl sulfate-d5 sodium salt (EtS-d5) (cat.# 34104)
Diluent:0.1% Formic acid in water
Conc.:500 ng/mL
Inj. Vol.:10 µL
Mobile Phase
A:0.1% Formic acid in water
B:0.1% Formic acid in acetonitrile
Time (min)Flow (mL/min)%A%B
Ion Mode:ESI-
NotesA 500 ng/mL standard was prepared in oral fluid. 50 µL of the standard was diluted with 950 µL of a working internal standard (100 ng/mL EtG-d5 and EtS-d5 in 0.1% formic acid in water). The sample was vortexed at 3000 rpm for 10 seconds to mix. The sample was then centrifuged at 3000 rpm for 10 minutes at 10 °C. The autosampler needle was adjusted to inject from the supernatant.